Clinical trials
Respiration Disorders trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Unknown status | 3 |
| Suspended | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 2 |
| Merck Sharp & Dohme LLC | 2 |
| AstraZeneca | 1 |
| Bellus Health Inc. - a GSK company | 1 |
| Cardenal Herrera University | 1 |
| Clinica Gema Leon | 1 |
| Consorcio Centro de Investigación Biomédica en Red (CIBER) | 1 |
| Debiopharm International SA | 1 |
| Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 1 |
| Hospital General Universitario de Valencia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Respiration Disorders | 20 |
| COVID-19 | 4 |
| Cough | 4 |
| Pulmonary Disease, Chronic Obstructive | 4 |
| Chronic Cough | 3 |
| Lung Diseases | 3 |
| Respiratory Tract Diseases | 3 |
| Signs and Symptoms, Respiratory | 3 |
| Dyspnea | 2 |
| Respiratory Distress Syndrome | 2 |
Trials
Showing 51 to 20 of 20. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.